BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis
August 19, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Aug. 19, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark" or the "Company") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF), a leader in next-generation diagnostics using...
BioMark Diagnostics Unveils U.S. Strategy
August 13, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Aug. 13, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark" or the "Company") (CSE:BUX) (FSE:20B), a leader in next-generation diagnostics using metabolites,...
BioMark Appoints Dr. Thomas Malcolm to Lead U.S. Operations
August 11, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Aug. 11, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce the appointment of Thomas Malcolm, Ph.D.,...